MLchartDataset catalogue

ALVAC gp100 vaccine

Term · Oncology and biomedicine · MLC-T-ONC-010002

A vaccine composed of the replication-defective plaque purified recombinant canarypox virus (ALVAC) that encodes the glycoprotein 100 (gp100) gene, with potential antineoplastic activity. Vaccination with ALVAC gp100 may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells positive for the gp100 melanoma antigen, resulting in decreased tumor growth.

Table 1. Record
IdentifierMLC-T-ONC-010002
FieldOncology and biomedicine
SynonymsALVAC gp-100 vaccine; gp100 ALVAC vaccine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-010002",
  "term": "ALVAC gp100 vaccine",
  "field": "Oncology and biomedicine",
  "definition": "A vaccine composed of the replication-defective plaque purified recombinant canarypox virus (ALVAC) that encodes the glycoprotein 100 (gp100) gene, with potential antineoplastic activity. Vaccination with ALVAC gp100 may stimulate the host immune system to mount a cytotoxic T-lymphocyte (CTL) response against tumor cells positive for the gp100 melanoma antigen, resulting in decreased tumor growth.",
  "synonyms": [
    "ALVAC gp-100 vaccine",
    "gp100 ALVAC vaccine"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/alvac-gp100-vaccine/"
}

Record 917 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.